See also this year's filing and all EDGAR filings for this company.
PDF Report 0001069530_2014_Filana_Therapeutics_INC.pdf
Logs
Graph
Absolute values for 0001069530, Filana Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 50,103,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 1,801,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,837,000 |
| 9 | ResearchAndDevelopmentExpense | 4,917,000 |
| 10 | remainder_Expenses | -73,000 |
| 11 | remainder_Revenues | 41,225,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -3,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 50,103,000 |
| 1 | Liabilities | 1,801,000 |
| 2 | Expenses | 9,681,000 |
| 3 | Revenues | 41,225,000 |
| 4 | StockholdersEquity | 48,302,000 |
| 5 | NetIncome | 31,544,000 |
| 6 | ComprehensiveNetIncome | 31,542,500 |
| 7 | BaseVar | 51,406,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 5.27 |
| 9 | EconomicCapitalRatio | 5.43 |
Edgar->Model Mapping
Feature Distribution
Change over Time
